Madison Area Lyme Support Group

Dr. Stricker at MyLymeData Conference

  May 17, 2017

LymeDisease.org board member Dr. Raphael Stricker, who serves as co-principal investigator of MyLymeData, spoke about big data, big pharma, and precision medicine.

Fantastic 30 minutes of great information.  My only comment is that I found myself fitting into the irregular group that had Lyme arthritis (swollen, red, hot to the touch knee with fever) as well as a itchy ringed rash that appeared after I started treatment.  Personally, I’m glad I was being treated for Tick Borne Illness and not Ringworm!  I’m also thankful for his reminder of the sexual transmission aspect that everyone seems to be dodging as well as the faulty testing.

May Support Group Reminder

Picture taken at the Lyme Protest in Madison in 2014.  

Photos courtesy of Della Haugen (Della’s story here):  https://madisonarealymesupportgroup.com/2010/05/08/my-lyme-story-writen-for-lymenaides/

**Our last support group meeting until fall** is this Wednesday, May 17 (2017) from 6:00pm-8:30pm at the Pinney Library on 204 Cottage Grove Road, Madison, WI.

Bring questions, ideas, and share what’s been working for you.

See you there!

My first Lyme rally when I was sicker than a dog.  I was impressed then and I’m impressed now with the dedication of Lyme/MSIDS patients and advocates despite an illness that brings you to your knees.  (I’ve got my hand up)

Systemic Review of Cerebrovascular Manifestations of LD

http://journal.frontiersin.org/article/10.3389/fneur.2017.00146/full

Frontiers in Neurology,  20 April 2017

Cerebrovascular Manifestations of Lyme Neuroborreliosis—A Systematic Review of Published Cases

Adam Garkowski¹*, Joanna Zajkowska², Agata Zajkowska³, Alina Kułakowska³,Olga Zajkowska⁴, Bożena Kubas⁵, Dorota Jurgilewicz⁵, Marcin Hładuński⁵ andUrszula Łebkowska¹

• ¹Department of Radiology, Medical University of Białystok, Białystok, Poland
• ²Department of Infectious Diseases and Neuroinfections, Medical University of Białystok, Białystok, Poland
• ³Department of Neurology, Medical University of Białystok, Białystok, Poland
• ⁴Faculty of Applied Informatics and Mathematics, Warsaw University of Life Sciences SGGW, Warsaw, Poland
• ⁵Independent Department, Laboratory of Molecular Imaging, Medical University of Białystok, Białystok, Poland

Background: Lyme neuroborreliosis (LNB) is a disease caused by spirochete Borrelia burgdorferi, involving the nervous system. It usually manifests as lymphocytic meningoradiculitis, but in rare cases, it can also lead to cerebrovascular complications. We aimed to perform a systematic review of all reported cases of LNB complicated by central nervous system vasculitis and stroke or transient ischemic attack (TIA).

Materials and methods: We conducted a systematic review of literature between May 1987 and December 2016 with patients who presented with cerebrovascular course of LNB.

Results: This study included 88 patients with a median age of 46 years. The median interval from onset of symptoms suggesting Lyme disease to first symptoms of cerebrovascular manifestations of LNB was 3.5 months. The most common cerebrovascular manifestation of LNB was ischemic stroke (76.1%), followed by TIA –transient ischemic attack (11.4%). The posterior circulation was affected alone in 37.8% of patients, the anterior circulation in 24.4% of patients, and in 37.8% of cases, posterior and anterior circulations were affected simultaneously. The most common affected vessels were middle cerebral artery—in 19 cases, basilar artery—in 17 cases, and anterior cerebral artery—in 16 cases. A good response to antibiotic treatment was achieved in the vast number of patients (75.3%). The overall mortality rate was 4.7%.

Conclusion: Cerebral vasculitis and stroke due to LNB should be considered, especially in patients who live in or have come from areas with high prevalence of tick-borne diseases, as well as in those without cardiovascular risk factors, but with stroke-like symptoms of unknown cause.

Supplementary Material
The Supplementary Material for this article can be found online at http://journal.frontiersin.org/article/10.3389/fneur.2017.00146/full#supplementary-material.  **This data shows year of publication, signs and symptoms, CSF protein level, Radiological/histopathological features, treatment, and outcome (complete or incomplete).  (Treatments included:  penicillin, steroids, ceftriaxone, doxycycline, amoxicillin, azithromycin, probenecid, cyclophosphamide, cefotaxime, and ampicillin)